ARCHIVES

[1]. Y. Chen, Y. Zhang, F. Pan, J. Liu, K. Wang, C. Zhang, S. Cheng, L. Lu, W. Zhang, Z. Zhang, “Breath analysis based on surface-
enhanced Raman scattering Sensors distinguishes early and advanced gastric cancer patients from healthy persons,” ACS Nano.
[2]. K.K. Farman Farma, N. Mahdavi far, S. Hassanipour, H. Salehiniya, “Epidemiologic study of gastric cancer in Iran: A systematic
review,” Clin. Exp. Gastroenterol..
[3]. A. Jemal et al., “Global cancer statistics,” CA Cancer J. Clin., 61, 69–90, https://doi.org/10.3322/caac.20107, Erratum in: CA Cancer
J. Clin. 61, 134 (2011).
[4]. “GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide.”
[5]. M. Mahmood, B. Al-Khateeb, W.M. Alwash, “A review on neural networks approach on classifying cancers,” Int. J. Artif. Intell.,
9(2), 317–326 (2020).
[6]. A.M. Brushfield, T.T. Luu, B.D. Callahan, P.E. Gilbert, “A comparison of discrimination and reversal learning for olfactory and
visual stimuli in aged rats,” Behav. Neurosci., 122(1), 54–62 (2008).
[7]. H. Sung et al., “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185
countries,” CA: a Cancer J. Clin., 71, 209–249 (2021).
[8]. E.C. Smyth, M. Nilsson, H.I. Grabsch, N.C. van Grieken, F. Lordick, “Gastric cancer,” Lancet, 396, 635–648 (2020).
[9]. K.S. Choi et al., “Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening
Programme in Korea,” Br. J. Cancer, 112, 608–612 (2015).
[10]. X. Zhang et al., “Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: a meta-analysis and
systematic review,” Gastroenterology, 155, 347–354.e9 (2018).
[11]. J.K. Jun et al., “Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality,”
Gastroenterology, 152, 1319–1328.e7 (2017).
[12]. Japanese Gastric Cancer Association, “Japanese gastric cancer treatment guidelines 2021,” Gastric Cancer, 26, 1–25 (2023).
[13]. H. Isomoto et al., “Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study,” Gut, 58, 331–336
(2009).
[14]. S.C. Shah, M.B. Piazuelo, E.J. Kuipers, D. Li, “AGA clinical practice update on the diagnosis and management of atrophic gastritis:
expert review,” Gastroenterology, 161, 1325–1332.e7 (2021).
[15]. D.L. Snyder, A.M. Hammoud, R.L. White, “Image recovery from data acquired with a charge-coupled-device camera,” JOSA A, 10,
1014–1023 (1993).
[16]. K. Yao, T. Yao, T. Matsui, A. Iwashita, T. Oishi, “Hemoglobin content in intramucosal gastric carcinoma as a marker of histologic
differentiation: a clinical application of quantitative electronic endoscopy,” Gastrointest. Endosc., 52, 241–245 (2000).
[17]. N. Uedo et al., “Differences in routine esophagogastroduodenoscopy between Japanese and international facilities: a questionnaire
survey,” Dig. Endosc., 28, 16–24 (2016).
[18]. K. Yao et al., “Guidelines for endoscopic diagnosis of early gastric cancer,” Dig. Endosc., 32, 663–698 (2020).
[19]. H. Doyama, H. Nakanishi, K. Yao, “Image-enhanced endoscopy and its corresponding histopathology in the stomach,” Gut Liver,
15, 329 (2021).
[20]. Y.T. Lee et al., “EUS-guided injection of cyanoacrylate for bleeding gastric varices,” Gastrointest. Endosc., 52, 168–174 (2000).
[21]. J.M. Kim et al., “Pre-and post-ESD discrepancies in clinicopathologic criteria in early gastric cancer: the NECA–Korea ESD for Early
Gastric Cancer Prospective Study (N-Keep),” Gastric Cancer, 19, 1104–1113 (2016).
[22]. A. Cerussi et al., “In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband
diffuse optical spectroscopy,” J. Biomed. Opt., 11 (2006).
[23]. D.J. Waterhouse, C.R. Fitzpatrick, B.W. Pogue, J.P. O’Connor, S.E. Bohndiek, “A roadmap for the clinical implementation of optical
imaging biomarkers,” Nat. Biomed. Eng., 3, 339–353 (2019).
[24]. J. Yoon, “Hyperspectral imaging for clinical applications,” BioChip J., 16, 1–12 (2022).
[25]. G. Lu, B. Fei, “Medical hyperspectral imaging: a review,” J. Biomed. Opt., 19, 010901 (2014).
[26]. J. Yoon et al., “A clinically translatable hyperspectral endoscopy (HySE) system for imaging the gastrointestinal tract,” Nat.
Commun., 10, 1902 (2019).
[27]. J. Yoon et al., “First experience in clinical application of hyperspec tral endoscopy for evaluation of colonic polyps,” J. Biophotonics,
14, e202100078 (2021).
[28]. R. Leon et al., “VNIR–NIR hyperspectral imaging fusion targeting intraoperative brain cancer detection,” Sci. Rep., 11, 19696 (2021).
[29]. H. Mangotra, S. Srivastava, G. Jaiswal, R. Rani, A. Sharma, “Hyper spectral imaging for early diagnosis of diseases: a review,”
Expert Syst., 40, e13311 (2023).[30]. U. Khan, S. Paheding, C.P. Elkin, V.K. Devabhaktuni, “Trends in deep learning for medical hyperspectral image analysis,” IEEE
Access, 9, 79534–79548 (2021).
[31]. J. Cordonnier, A. Loukas, M. Jaggi, “On the relationship between self attention and convolutional layers,” arXiv preprint
arXiv:1911.03584 (2019).
[32]. A. Dosovitskiy et al., “An image is worth 16x16 words: Transformers for image recognition at scale,” arXiv preprint
arXiv:2010.11929 (2020).
[33]. S. Trajanovski, C. Shan, P.J. Weijtmans, S.G.B. de Koning, T.J. Ruers, “Tongue tumor detection in hyperspectral images using deep
learning semantic segmentation,” IEEE Trans. Biomed. Eng., 68, 1330–1340 (2020).
[34]. F.B. Muniz, M. d F.O. Baffa, S.B. Garcia, L. Bachmann, J.C. Felipe, “Histopathological diagnosis of colon cancer using micro-FTIR
hyper spectral imaging and deep learning,” Comput. Methods Prog. Biomed., 231, 107388 (2023).
[35]. I.A. Cruz-Guerrero et al., “Hybrid brain tumor classification of histopathology hyperspectral images by linear unmixing and an
ensemble of deep neural networks,” Healthc. Technol. Lett., 11, 240–251 (2024).
[36]. B.J. Tromberg et al., “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia, 2,
26–40 (2000)